Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)

Clinical Neurology

Volumn 36, Issue 12, 1996, Pages 1329-1330

  Yanagisawa, Nobuo ^a   Shindo, Masaomi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

amyotrophic lateral sclerosis (ALS); clinical evaluation; glutamate antagonists; neutroprotection

Indexed keywords

EXCITATORY AMINO ACID; FREE RADICAL; NEUROTROPHIC FACTOR; RILUZOLE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; NERVE CELL NECROSIS; NEUROPROTECTION;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; NEUROPROTECTIVE AGENTS; RILUZOLE; THIAZOLES;

EID: 0030441578     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Bensimon G, Lacomblez L, Meinninger V, et al : A controlled trial of riluzole in amyotrophic lateral sclerosis. N Eng J Med 330 : 585-591, 1994
2. Ikeda K, Kinoshita M, Iwasaki Y, et al : Lecithinized superoxide dismutase retards wobbler mouse motoneurone disease. Neuromusc Disord 5 : 383-390, 1995